Skip to content
  • Clinical Studies
  • Schedule M
  • Stability Studies
  • Pharma GMP
  • Pharma Tips
  • Pharma Books
  • Pharma Validation
  • Pharma Regulatory

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • SOP Guidelines
    • SOP Development
    • SOP Training
    • SOP Compliance Monitoring
    • SOP Revision Processes
    • Pharmaceutical SOP templates
    • GMP documentation SOP
    • Data integrity SOP pharma
    • Manufacturing SOP pharmaceutical
    • FDA SOP guidance
    • eQMS SOP workflows
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • GMP Audit Findings
    • Non-Compliance
      • SOP Absence
      • Revision Control
      • Non-Adherence
      • Poor Writing
      • Training Failure
      • Data Integrity Gaps
      • Mismatch Between SOPs and Practice
      • Critical Operations
      • Regulatory Change
      • Emergency Changes
      • Third-Party SOPs
      • Inspection Readiness
      • Deviation Handling
      • CAPA Integration
      • Validation Alignment
      • System Integration
      • Uncontrolled Distribution
      • SOP Implementation Gaps
      • SOP Alignment with Validation
      • Change Control Linkage
  • Toggle search form

Analytical Method Development: SOP for System Suitability Checks for Chromatographic Methods – V 2.0

Posted on By

Analytical Method Development: SOP for System Suitability Checks for Chromatographic Methods – V 2.0

Standard Operating Procedure for System Suitability Checks in Chromatographic Methods within Analytical Method Development


Department Analytical Method Development
SOP No. SOP/AMD/336/2025
Supersedes SOP/AMD/336/2022
Page No. Page 1 of 14
Issue Date 01/06/2025
Effective Date 03/06/2025
Review Date 01/06/2026

1. Purpose

The purpose of this SOP is to describe the procedures for conducting and evaluating system suitability tests (SST) to ensure the performance of chromatographic systems (HPLC,

GC, UPLC) used in analytical method development meets defined criteria before or during analysis.

2. Scope

This SOP applies to all chromatographic methods developed, validated, or transferred within the Analytical Method Development (AMD) department, including those used for product characterization, impurities profiling, and routine analytical tasks.

3. Responsibilities

  • Analyst: Perform SST before sample analysis and document results.
  • Reviewer (QA or Supervisor): Verify SST compliance and ensure proper documentation.
  • AMD Head: Approve SST protocols and evaluate repeat SST failures.
See also  Analytical Method Development: SOP for Blend Uniformity Testing Method - V 2.0

4. Accountability

The AMD Head shall be accountable for ensuring that only systems that meet system suitability criteria are used for analytical testing and that failures are investigated promptly.

5. Procedure

5.1 General Requirements

  1. System suitability must be evaluated before analyzing test samples.
  2. Use the same column, system, and method parameters as mentioned in the analytical procedure.
  3. Record SST results in the system suitability log (Annexure-1) and attach to raw data packet.

5.2 System Suitability Parameters

Parameters typically evaluated include:

  • Retention time (tR): Consistency of analyte elution
  • Resolution (Rs): Minimum between two closely eluting peaks
  • Theoretical plates (N): Column efficiency
  • Tailing factor (T): Peak symmetry (should be between 0.9–2.0)
  • Relative standard deviation (RSD): Peak area or retention time reproducibility from replicate injections

5.3 SST Preparation

  1. Prepare fresh mobile phase, system suitability solution, and column as specified.
  2. Condition the system for at least 30 minutes before injecting SST solution.
  3. Inject minimum five replicates of SST solution to determine system parameters.
See also  Analytical Method Development: SOP for Plume Geometry Analysis Method Development - V 2.0

5.4 Evaluation Criteria

Acceptable limits may vary depending on the method, but as general guidelines:

  • RSD: ≤2.0% for peak area or retention time
  • Resolution: ≥2.0 between critical pairs
  • Tailing Factor: ≤2.0 for principal peaks
  • Theoretical Plates: ≥2000 for analytical peaks

5.5 Handling SST Failures

  1. Do not proceed with analysis if SST fails.
  2. Document failure and perform investigation using a checklist (Annexure-2).
  3. Check for mobile phase composition errors, column deterioration, instrument malfunction, or operator error.
  4. If cause is confirmed and corrected, repeat SST.
  5. Recurring SST failures must be escalated to AMD Head for CAPA initiation.

5.6 Documentation

  1. Record all SST values, chromatograms, and calculations in the system suitability record form (Annexure-1).
  2. Sign and date all entries.
  3. Review and verify SST results before proceeding with test samples.

6. Abbreviations

  • HPLC: High Performance Liquid Chromatography
  • GC: Gas Chromatography
  • SST: System Suitability Test
  • RSD: Relative Standard Deviation
  • CAPA: Corrective and Preventive Action
See also  Analytical Method Development: SOP for pH Determination of Semi-Solid Formulations - V 2.0

7. Documents

  1. Annexure-1: System Suitability Log Template
  2. Annexure-2: SST Failure Investigation Checklist

8. References

  • USP <621> Chromatography
  • ICH Q2(R1) – Validation of Analytical Procedures
  • FDA Guidance for Industry – Chromatographic Methods

9. SOP Version

Version: 2.0

10. Approval Section

Prepared By Checked By Approved By
Signature
Date
Name Manoj Tiwari Sunita Rao Dr. Anurag Singh
Designation Analyst QA Officer Head – AMD
Department Analytical Method Development Quality Assurance Analytical Method Development

11. Annexures

Annexure-1: System Suitability Log Template

Date Method Injection RSD (%) Resolution Tailing Theoretical Plates Status
01/06/2025 Ibuprofen Assay 5 1.2 2.5 1.1 3800 Pass

Annexure-2: SST Failure Investigation Checklist

  • Was mobile phase prepared correctly?
  • Is column within qualification life?
  • Is instrument showing any error?
  • Was system adequately equilibrated?
  • Any sample preparation issues?

Revision History:

Revision Date Revision No. Details Reason Approved By
01/06/2025 2.0 Included UPLC, SST failure flowchart, and updated annexures Annual SOP revision Dr. Anurag Singh
10/05/2022 1.0 Initial Release New SOP QA Head
Analytical Method Development V 2.0 Tags:Analytical Method Development SOP, SOP for analytical calculations, SOP for analytical documentation, SOP for analytical instrument calibration, SOP for analytical instrument qualification, SOP for analytical method change control, SOP for analytical method deviation handling, SOP for analytical method documentation practices, SOP for analytical method lifecycle management, SOP for analytical method optimization, SOP for analytical method risk assessment, SOP for analytical method training and competency, SOP for analytical method transfer protocol, SOP for analytical method validation, SOP for forced degradation studies, SOP for HPLC method development, SOP for limit of detection (LOD) determination, SOP for limit of quantitation (LOQ) determination, SOP for method accuracy testing, SOP for method linearity assessment, SOP for method precision evaluation, SOP for method reproducibility, SOP for method robustness testing, SOP for method transfer, SOP for method verification, SOP for qualification of working standards, SOP for reference standard handling, SOP for specificity testing in analytical methods, SOP for stability indicating methods, SOP for system suitability testing

Post navigation

Previous Post: Elixir Department: SOP for Alcohol Evaporation Rate – V 2.0
Next Post: Analytical Method Development: SOP for System Performance Qualification of UV-Visible Spectrophotometer – V 2.0

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Gels V 2.0
  • Injectables V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2026 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version